Publications

  1. Toesca DAS, Hartsell WF, DeWees TA, Chang JH, Laughlin BS, Voss MM, Dodoo CA, Mohammed N, Keole SR, McGee LA, Gondi V, Sweeney PJ, Dorn P, Sinesi CC, Doh LS, Rich T, Vargas CE. Stereotactic Body Proton Therapy Versus Conventionally Fractionated Proton Therapy for Early Prostate Cancer: A Randomized, Controlled, Phase 3 Trial. Int J Radiat Oncol Biol Phys. 2024 Dec 1; 120 (5):1377-1385 Epub 2024 July 06
    View PubMed
  2. Chen J, Yang Y, Feng H, Zhang L, Liu Z, Liu T, Vargas CE, Yu NY, Rwigema JM, Keole SR, Patel SH, Vora SA, Shen J, Liu W. Robust Optimization for Spot Scanning Proton Therapy based on Dose-Linear Energy Transfer (LET) Volume Constraints. Int J Radiat Oncol Biol Phys. 2024 Nov 15 [Epub ahead of print]
    View PubMed
  3. Duan J, Tegtmeier RC, Vargas CE, Yu NY, Laughlin BS, Rwigema JM, Anderson JD, Zhu L, Chen Q, Rong Y. Achieving accurate prostate auto-segmentation on CT in the absence of MR imaging. Radiother Oncol. 2024 Oct 16; 202:110588 [Epub ahead of print]
    View PubMed
  4. Feng H, Shan J, Vargas CE, Keole SR, Rwigema JM, Yu NY, Ding Y, Zhang L, Hu Y, Schild SE, Wong WW, Vora SA, Shen J, Liu W. Online Adaptive Proton Therapy Facilitated by Artificial Intelligence-Based Autosegmentation in Pencil Beam Scanning Proton Therapy. Int J Radiat Oncol Biol Phys. 2024 Sep 20 Epub 2024 Sept 20
    View PubMed
  5. Mutter RW, Golafshar MA, Buras MR, Comstock BP, Jacobson M, DeWees T, Remmes NB, Francis LN, Boughey JC, Ruddy KJ, McGee LA, Afzal A, Vallow LA, Furutani KM, Deufel CL, Shumway DA, Kim H, Liu MC, Degnim AC, Jakub JW, Vern-Gross TZ, Wong WW, Patel SH, Vargas CE, Stish BJ, Waddle MR, Pafundi DH, Halyard MY, Corbin KS, Hieken TJ, Park SS. Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial. Int J Radiat Oncol Biol Phys. 2024 Sep 17 Epub 2024 Sept 17
    View PubMed
  6. Tegtmeier RC, Clouser EL, Laughlin BS, Santos Toesca DA, Flakus MJ, Bashir S, Kutyreff CJ, Hobbis D, Harrington DP, Smetanick JL, Yu NY, Vargas CE, James SE, Rwigema JM, Rong Y. Evaluation of knowledge-based planning models for male pelvic CBCT-based online adaptive radiotherapy on conventional linear accelerators. J Appl Clin Med Phys. 2024 Sep; 25 (9):e14464 Epub 2024 July 19
    View PubMed
  7. Choi JI, Hardy-Abeloos C, Lozano A, Hanlon A, Vargas C, Maduro JH, Bradley J, Offersen B, Haffty B, Pankuch M, Amos R, Kim N, MacDonald SM, Kirova Y, Mutter RW. PTCOG international survey of practice patterns and trends in utilization of proton therapy for breast cancer. Clin Transl Radiat Oncol. 2024 Sep; 48:100847 Epub 2024 Aug 27
    View PubMed
  8. Valdes G, Scholey J, Nano TF, Gennatas ED, Mohindra P, Mohammed N, Zeng J, Kotecha R, Rosen LR, Chang J, Tsai HK, Urbanic JJ, Vargas CE, Yu NY, Ungar LH, Eaton E, Simone CB 2nd. Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial. Int J Radiat Oncol Biol Phys. 2024 May 1; 119 (1):66-77 Epub 2023 Nov 23
    View PubMed
  9. Hotca A, Sindhu KK, Lehrer EJ, Hartsell WF, Vargas C, Tsai HK, Chang JH, Apisarnthanarax S, Nichols RC Jr, Chhabra AM, Hasan S, Press RH, Lazarev S, Hajj C, Kabarriti R, Rule WG, Simone CB 2nd, Choi JI. Reirradiation With Proton Therapy for Recurrent Malignancies of the Esophagus and Gastroesophageal Junction: Results of the Proton Collaborative Group Multi-Institutional Prospective Registry Trial. Adv Radiat Oncol. 2024 May; 9 (5):101459 Epub 2024 Feb 06
    View PubMed
  10. Valdes G, Scholey J, Nano TF, Gennatas ED, Mohindra P, Mohammed N, Zeng J, Kotecha R, Rosen LR, Chang J, Tsai HK, Urbanic JJ, Vargas CE, Yu NY, Ungar LH, Eaton E, Simone CB. Predicting the effect of proton beam therapy technology on pulmonary toxicities for patients with locally advanced lung cancer enrolled in the proton collaborative group prospective clinical trial. International Journal of Radiation Oncology Biology Physics. 2024 May 1; 119 (1):66-77
  11. Laughlin BS, Corbin KS, Toesca DAS, Thorpe CS, Golafshar MA, Pockaj B, Cronin P, McGee LA, Halyard MY, Mutter RW, Keole SR, Park SS, Shumway DA, Vern-Gross TZ, Vallow L, Wong WW, DeWees TA, Vargas CE. Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery. Int J Radiat Oncol Biol Phys. 2024 Mar 15; 118 (4):1049-1059 Epub 2023 Oct 31
    View PubMed
  12. Shen J, Taylor PA, Vargas CE, Kang M, Saini J, Zhou J, Wang P, Liu W, Simone CB 2nd, Xiao Y, Lin L. The Status and Challenges for Prostate Stereotactic Body Radiation Therapy Treatments in United States Proton Therapy Centers: An NRG Oncology Practice Survey. Int J Part Ther. 2024 Mar; 11:100020 Epub 2024 Apr 24
    View PubMed
  13. Zhang L, Holmes JM, Liu Z, Vora SA, Sio TT, Vargas CE, Yu NY, Keole SR, Schild SE, Bues M, Li S, Liu T, Shen J, Wong WW, Liu W. Beam mask and sliding window-facilitated deep learning-based accurate and efficient dose prediction for pencil beam scanning proton therapy. Med Phys. 2024 Feb; 51 (2):1484-1498 Epub 2023 Sept 25
    View PubMed
  14. Mumaw DA, Hazy AJ, Vayntraub A, Quinn TJ, Salari K, Chang JH, Kalman N, Katz S, Urbanic J, Press RH, Thukral AD, Tsai H, Laramore GE, Molitoris J, Vargas C, Patel SH, Stevens C, Deraniyagala RL. Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group. Radiother Oncol. 2024 Jan; 190:109977 Epub 2023 Nov 02
    View PubMed
  15. Sperduto W, Voss MM, Laughlin B, Toesca DAS, Wong WW, Keole SR, Rwigema JCM, Yu NY, Schild SE, James SE, Daniels TB, DeWees TA, Vargas CE. Five-year prostate-specific membrane antigen positron emission tomography-based outcomes of spot-scanning proton radiation therapy for localized prostate cancer: a single institution experience. Advances in Radiation Oncology. 2024; 9 (11):101639
  16. Laughlin BS, Anderson JD, Hobbis D, Armstrong M, Vargas CE, Rong Y, Yu NY. Energy use in moderate hypofractionation and stereotactic body radiotherapy for prostate cancer. BJU Int. 2023 Dec; 132 (6):648-650 Epub 2023 Aug 21
    View PubMed
  17. Tian S, McCook A, Choi IJ, Simone CB 2nd, Vargas CE, Yu NY, Chang JHC, Mihalcik SA, Tsai H, Zeng J, Rosen LR, Rana ZH, Urbanic JJ, Stokes WA, Kesarwala AH, Bradley JD, Higgins KA. Treatment of Thymoma and Thymic Carcinoma with Proton Beam Therapy: Outcomes from the Proton Collaborative Group Prospective Registry. Int J Radiat Oncol Biol Phys. 2023 Oct 1; 117 (2S):e66
    View PubMed
  18. Ding Y, Holmes J, Li B, Vargas CE, Vora SA, Wong WW, Fatyga M, Foote RL, Patel SH, Liu W. Patient-Specific 3D CT Images Reconstruction from 2D KV Images Via Vision Transformer-Based Deep-Learning. Int J Radiat Oncol Biol Phys. 2023 Oct 1; 117 (2S):e660
    View PubMed
  19. Mutter RW, Giri S, Fruth BF, Remmes NB, Boughey JC, Harless CA, Ruddy KJ, McGee LA, Afzal A, Gao RW, Shumway DA, Vern-Gross TZ, Villarraga HR, Kenison SL, Kang Y, Wong WW, Stish BJ, Merrell KW, Yan ES, Park SS, Corbin KS, Vargas CE. Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial. Lancet Oncol. 2023 Oct; 24 (10):1083-1093 Epub 2023 Sept 08
    View PubMed
  20. Kang Y, Bues M, Halyard MY, McGee LA, Vern-Gross TZ, Wong WW, Keole SR, Vargas C, James SE, Ahmed SK, Archuleta JP, Ridgway AK, Lara PR, Fatyga M. Dose delivery reproducibility for PBS proton treatment of breast cancer patients with and without mask immobilization. Radiat Oncol. 2023 Sep 22; 18 (1):157 Epub 2023 Sept 22
    View PubMed
  21. Eckstein J, Choi JI, Lozano A, Ohri N, Press R, Hasan S, Kabarriti R, Chang J, Urbanic J, Durci M, Mohammed N, Stevens C, Tsai H, Apisarnthanarax S, Regine W, Vargas C, Nichols R Jr, Herman J, Simone CB 2nd, Chhabra A. Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry. Adv Radiat Oncol. 2023 Sep-Oct; 8 (5):101250 Epub 2023 Apr 23
    View PubMed
  22. Duan J, Vargas CE, Yu NY, Laughlin BS, Toesca DS, Keole S, Rwigema JCM, Wong WW, Schild SE, Feng X, Chen Q, Rong Y. Incremental retraining, clinical implementation, and acceptance rate of deep learning auto-segmentation for male pelvis in a multiuser environment. Med Phys. 2023 Jul; 50(7):4079-4091. Epub 2023 Jun 07.
    View PubMed
  23. Hasan S, Lazarev S, Garg M, Gozland R, Chang J, Hartsell W, Chen J, Tsai H, Vargas C, Simone CB 2nd, Gorovets D. Proton therapy for high-risk prostate cancer: Results from the Proton Collaborative Group PCG 001-09 prospective registry trial. Prostate. 2023 Jun; 83 (9):850-856 Epub 2023 Mar 22
    View PubMed
  24. Chhabra AM, Rice SR, Holtzman A, Choi JI, Hasan S, Press RH, Chang J, Halasz L, Tsai HK, Wang CJ, Kabolizadeh P, Gondi V, Hartsell WF, Vora SA, Vargas CE, Simone CB 2nd. Clinical outcomes and toxicities of 100 patients treated with proton therapy for chordoma on the proton collaborative group prospective registry. Radiother Oncol. 2023 Jun; 183:109551 Epub 2023 Feb 20
    View PubMed
  25. Laughlin BS, Thorpe CS, DeWees TA, Voss MM, Chang JH, Hartsell WF, Sinesi CC, Rwigema JM, Keole SR, Gondi V, Vargas CE. Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003. Adv Radiat Oncol. 2023 May-Jun; 8 (3):101142 Epub 2022 Dec 09
    View PubMed
  26. Choo R, Hillman DW, Mitchell C, Daniels T, Vargas C, Rwigema JC, Corbin K, Keole S, Vora S, Merrell K, Stish B, Pisansky T, Davis BJ, Amundson A, Wong W. Late Toxicity of Moderately Hypofractionated Intensity-Modulated Proton Therapy Treating the Prostate and Pelvic Lymph Nodes for High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2023 Apr 1; 115 (5):1085-1094 Epub 2022 Nov 22
    View PubMed
  27. Laughlin BS, Voss MM, Toesca DAS, Daniels T, Golafshar MA, Keole SR, Wong WW, Rwigema JC, Davis B, Schild SE, Stish BJ, Choo R, Lester S, DeWees TA, Vargas CE. Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy. Adv Radiat Oncol. 2023 Mar-Apr; 8 (2):101143 Epub 2022 Dec 10
    View PubMed
  28. Laughlin BS, Narang GL, Cheney SM, Humphreys MR, Vargas CE, Keole SR, Rwigema JM, Schild SE, Wong WW. Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience. Cancer Rep (Hoboken). 2023 Jan; 6 (1):e1672 Epub 2022 July 05
    View PubMed
  29. Hobbis D, Yu NY, Mund KW, Duan J, Rwigema JM, Wong WW, Schild SE, Keole SR, Feng X, Chen Q, Vargas CE, Rong Y. First Report On Physician Assessment and Clinical Acceptability of Custom-Retrained Artificial Intelligence Models for Clinical Target Volume and Organs-at-Risk Auto-Delineation for Postprostatectomy Patients. Pract Radiat Oncol. 2023 Jul-Aug; 13(4):351-362. Epub 2023 Apr 06.
    View PubMed
  30. Thorpe CS, DeWees TA, Laughlin BS, Vallow LA, Seneviratne D, Pockaj BA, Cronin PA, Halyard MY, Vern-Gross TZ, McGee LA, McLaughlin SA, Voss MM, Golafshar MA, Bulman GF, Vargas CE. Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery. Adv Radiat Oncol. 2023 Jan-Feb; 8 (1):101111 Epub 2022 Oct 21
    View PubMed
  31. Laughlin BS, Yu NY, Lo S, Duan J, Welchel Z, Tinnon K, Beckett M, Schild SE, Wong WW, Keole SR, Rwigema JM, Vargas CE, Rong Y. Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image Guidance. Cancers (Basel). 2022 Dec 21; 15 (1)
    View PubMed
  32. Laughlin BS, Lo S, Vargas CE, DeWees TA, Van der Walt C, Tinnon K, Beckett M, Hobbis D, Schild SE, Wong WW, Keole SR, Rwigema JM, Yu NY, Clouser E, Rong Y. Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 1: Consistent Organs at Risk Management with Advanced Image Guidance. Cancers (Basel). 2022 Dec 20; 15 (1)
    View PubMed
  33. Yang Y, Rwigema JM, Vargas C, Yu NY, Keole SR, Wong WW, Schild SE, Bues M, Liu W, Shen J. Technical note: Investigation of dose and LET(d) effect to rectum and bladder by using non-straight laterals in prostate cancer receiving proton therapy. Med Phys. 2022 Dec; 49 (12):7428-7437 Epub 2022 Oct 18
    View PubMed
  34. Choi JI, Prabhu K, Hartsell WF, DeWees T, Sinesi C, Vargas C, Benda RK, Cahlon O, Chang AL. Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial. Clin Transl Radiat Oncol. 2022 Nov; 37:71-77 Epub 2022 Aug 28
    View PubMed
  35. Kowalchuk RO, Kim H, Harmsen WS, Jeans EB, Morris LK, Mullikin TC, Miller RC, Wong WW, Vargas CE, Trifiletti DM, Phillips RM, Choo CR, Davis BJ, Beriwal S, Tendulkar RD, Stish BJ, Breen WG, Waddle MR. Cost effectiveness of treatment strategies for high risk prostate cancer. Cancer. 2022 Nov 1; 128 (21):3815-3823 Epub 2022 Sept 07
    View PubMed
  36. Wong WW, Hillman DW, Daniels TB, Vargas CE, Rwigema JC, Corbin KS, Keole SR, Merrell KW, Stish BJ, Pisansky TM, Davis BJ, Mitchell CM, Choo R. A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient-reported quality of life. Prostate. 2022 Oct; 82 (14):1338-1345 Epub 2022 July 05
    View PubMed
  37. Bhangoo RS, Cheng TW, Petersen MM, Thorpe CS, DeWees TA, Anderson JD, Vargas CE, Patel SH, Halyard MY, Schild SE, Wong WW. Radiation recall dermatitis: A review of the literature. Semin Oncol. 2022 Apr; 49 (2):152-159 Epub 2022 Apr 29
    View PubMed
  38. Bhangoo RS, Petersen MM, Bulman GF, Vargas CE, Thorpe CS, Shen J, Wong WW, Rwigema JM, Daniels TB, Keole SR, Schild SE, Rong Y, DeWees TA. Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer. Int J Part Ther. 2022 Spring; 8 (4):37-46 Epub 2021 Sept 08
    View PubMed
  39. Thorpe CS, DeWees TA, Golafshar MA, Bhangoo RS, Vern-Gross TZ, McGee LA, Wong WW, Halyard MY, Keole SR, Vargas CE. Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registry. J Patient Rep Outcomes. 2022 Jan 10; 6 (1):3
    View PubMed
  40. Jongen A, Charlier F, Baker K, Chang J, Hartsell W, Laramore G, Mohindra P, Moretti L, Redman M, Rosen L, Tsai H, Van Gestel D, Vargas C, Rengan R. Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective Registry. Adv Radiat Oncol. 2022 Jan-Feb; 7 (1):100767 Epub 2021 Sept 10
    View PubMed
  41. Laughlin BS, Bhangoo RS, Thorpe CS, Golafshar MA, DeWees TA, Anderson JD, Vern-Gross TZ, McGee LA, Wong WW, Halyard MY, Keole SR, Vargas CE. Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: A single-center registry experience. Front Oncol. 2022; 12:920739 Epub 2022 Aug 26
    View PubMed
  42. Laughlin BS, Bhangoo RS, Niska JR, Thorpe CS, Girardo ME, Anderson JD, Kosiorek HE, McGee LA, Hartsell WF, Chang JH, Rossi CJ, Tsai HK, Choi IJ, Vargas CE. Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone. Front Oncol. 2022; 12:925078. Epub 2022 Nov 28.
    View PubMed
  43. Bhangoo RS, DeWees TA, Thorpe CS, Petersen M, Hartsell WF, Chang J, Sinesi CC, Mishra MV, Mohammed N, McGee LA, Keole SR, Sweeney PJ, Gondi V, Vargas CE. Updated Toxicity and Quality-of-Life Outcomes From a Randomized Phase III Trial of Extreme Hypofractionated vs. Standard Fractionated Proton Therapy for Low-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2021 Nov 1; 111 (3S):e266
    View PubMed
  44. Thorpe CS, DeWees TA, Bhangoo RS, Petersen M, Chang JHC, Hartsell WF, Sinesi CC, Rwigema JC, Keole SR, Gondi V, Vargas CE. Randomized Phase III Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Adenocarcinoma of the Prostate: Analysis of Quality of Life and Toxicity, PCG GU 003. Int J Radiat Oncol Biol Phys. 2021 Nov 1; 111 (3S):e295
    View PubMed
  45. Kowalchuk RO, Hillman D, Daniels TB, Vargas CE, Rwigema JM, Wong WW, Stish BJ, Dueck AC, Choo R. Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer. Clin Transl Radiat Oncol. 2021 Nov; 31:34-41 Epub 2021 Sept 15
    View PubMed
  46. Golafshar MA, Petersen M, Vargas CE, Samadder NJ, Kunze KL, McCormick N, Watkin SA, Maleyeva D, Cheng TW, Vargas M, DeWees TA. Utilizing open-source platforms to build and deploy interactive patient-reported quality of life tracking tools for monitoring protocol adherence. Qual Life Res. 2021 Nov; 30 (11):3189-3197 Epub 2020 Sept 09
    View PubMed
  47. Thorpe CS, DeWees TA, Vallow LA, Pockaj BA, Cronin PA, Halyard MY, Vern-Gross TZ, McGee LA, Mclaughlin S, Golafshar MA, Bulman GF, Vargas CE. MC1732: Pilot/Phase II Trial of Hypofractionated Radiotherapy to the Whole Breast Alone Before Breast Conserving Surgery. Int J Radiat Oncol Biol Phys. 2021 Nov 1; 111(3S):S109. Epub 1900 Jan 01.
  48. Parzen JS, Chuong MD, Chang J, Rosen L, Urbanic J, Hartsell W, Tsai H, Sinesi C, Zeng J, Mishra M, Vargas C, Stevens C, Kabolizadeh P. Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial. Adv Radiat Oncol. 2021 Sep-Oct; 6 (5):100751 Epub 2021 July 15
    View PubMed
  49. Bryant CM, Henderson RH, Nichols RC, Mendenhall WM, Hoppe BS, Vargas CE, Daniels TB, Choo CR, Parikh RR, Giap H, Slater JD, Vapiwala N, Barrett W, Nanda A, Mishra MV, Choi S, Liao JJ, Mendenhall NP, Genitourinary Subcommittee of the Particle Therapy Co-Operative Group. Consensus Statement on Proton Therapy for Prostate Cancer. Int J Part Ther. 2021 Fall; 8 (2):1-16 Epub 2021 Apr 12
    View PubMed
  50. Choo R, Hillman DW, Daniels T, Vargas C, Rwigema JC, Corbin K, Keole S, Vora S, Merrell K, Stish B, Pisansky T, Davis B, Amundson A, Wong W. Proton Therapy of Prostate and Pelvic Lymph Nodes for High Risk Prostate Cancer: Acute Toxicity. Int J Part Ther. 2021 Fall; 8 (2):41-50 Epub 2021 Sept 14
    View PubMed
  51. Yang Y, Vargas CE, Bhangoo RS, Wong WW, Schild SE, Daniels TB, Keole SR, Rwigema JM, Glass JL, Shen J, DeWees TA, Liu T, Bues M, Fatyga M, Liu W. Exploratory Investigation of Dose-Linear Energy Transfer (LET) Volume Histogram (DLVH) for Adverse Events Study in Intensity Modulated Proton Therapy (IMPT). Int J Radiat Oncol Biol Phys. 2021 Jul 15; 110 (4):1189-1199 Epub 2021 Feb 20
    View PubMed
  52. Vapiwala N, Wong JK, Handorf E, Paly J, Grewal A, Tendulkar R, Godfrey D, Carpenter D, Mendenhall NP, Henderson RH, Stish BJ, Vargas C, Salama JK, Davis BJ, Horwitz EM. A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer Patients. Int J Radiat Oncol Biol Phys. 2021 Jul 15; 110 (4):1082-1089 Epub 2021 Feb 01
    View PubMed
  53. Bulman GF, Bhangoo RS, DeWees TA, Petersen MM, Thorpe CS, Wong WW, Rwigema JCM, Daniels TB, Keole SR, Schild SE, Vargas CE. Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapy. Radiat Oncol J. 2021 Jun; 39 (2):122-128 Epub 2021 June 24
    View PubMed
  54. Tseng YD, Pankuch M, Mohindra P, McGee L, Rossi C, Flampouri S, Hajj C, Molitoris JK, Chang JH, Tsai H, Stevens C, Rosen L, Vargas C, Hartsell W. Selection of Mediastinal Lymphoma Patients for Proton Therapy Within the Proton Collaborative Group Registry: Concordance With the ILROG Guidelines. Am J Clin Oncol. 2021 Jun 1; 44 (6):269-274
    View PubMed
  55. Anderson JD, Hammond JB, Kosiorek HE, Thorpe CS, Bhangoo RS, Pockaj BA, Gray RJ, Cronin PA, Rebecca AM, Casey WJ, Wong WW, Keole SR, Vern-Gross TZ, McGee LA, Halyard MY, DeWees TA, Vargas CE. Unplanned implant removal in locally advanced breast cancer. Breast J. 2021 May; 27 (5):466-471 Epub 2021 Mar 14
    View PubMed
  56. Hammond JB, Kosiorek HE, Cronin PA, Rebecca AM, Casey WJ 3rd, Wong WW, Vargas CE, Vern-Gross TZ, McGee LA, Pockaj BA. Capsular contracture in the modern era: A multidisciplinary look at the incidence and risk factors after mastectomy and implant-based breast reconstruction. Am J Surg. 2021 May; 221 (5):1005-1010 Epub 2020 Sept 21
    View PubMed
  57. Vargas CE, Thorpe CS, Dueck AC, Tenner KS, Davidson NE, Martino S, Pisansky TM, Hwang ES, Halyard MY, Pockaj BA, Perez EA. Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) study. Cancer. 2020 Dec 15; 126 (24):5239-5246 Epub 2020 Sept 15
    View PubMed
  58. Parzen JS, Hartsell W, Chang J, Apisarnthanarax S, Molitoris J, Durci M, Tsai H, Urbanic J, Ashman J, Vargas C, Stevens C, Kabolizadeh P. Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group. Radiat Oncol. 2020 Nov 4; 15 (1):255 Epub 2020 Nov 04
    View PubMed
  59. Thorpe CS, Niska JR, Anderson JD, Girardo ME, McGee LA, Hartsell WF, Larson GL, Tsai HK, Rossi CJ, Rosen LR, Vargas CE. Acute toxicities after proton beam therapy following breast-conserving surgery for breast cancer: Multi-institutional prospective PCG registry analysis. Breast J. 2020 Sep; 26 (9):1760-1764 Epub 2020 Apr 15
    View PubMed
  60. Saeed AM, Khairnar R, Sharma AM, Larson GL, Tsai HK, Wang CJ, Halasz LM, Chinnaiyan P, Vargas CE, Mishra MV. Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry. Adv Radiat Oncol. 2020 Sep-Oct; 5 (5):978-983 Epub 2020 Apr 22
    View PubMed
  61. Mishra MV, Khairnar R, Bentzen SM, Larson G, Tsai H, Sinesi C, Vargas C, Laramore G, Rossi C, Rosen L, Sun K, Hartsell W. Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-09. Clin Transl Radiat Oncol. 2020 May; 22:50-54 Epub 2020 Mar 07
    View PubMed
  62. Liu C, Patel SH, Shan J, Schild SE, Vargas CE, Wong WW, Ding X, Bues M, Liu W. Robust Optimization for Intensity Modulated Proton Therapy to Redistribute High Linear Energy Transfer from Nearby Critical Organs to Tumors in Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2020 May 1; 107 (1):181-193 Epub 2020 Jan 25
    View PubMed
  63. Chuong M, Bryant J, Hartsell W, Larson G, Badiyan S, Laramore GE, Katz S, Tsai H, Vargas C. Minimal acute toxicity from proton beam therapy for major salivary gland cancer. Acta Oncol. 2020 Feb; 59 (2):196-200 Epub 2019 Dec 05
    View PubMed
  64. Thorpe CS, Niska JR, Girardo ME, Kosiorek HE, McGee LA, Hartsell WF, Larson GL, Tsai HK, Rossi CJ, Rosen LR, Vargas CE. Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis. Breast J. 2019 Nov; 25 (6):1160-1170 Epub 2019 July 23
    View PubMed
  65. Mishra MV, Khairnar R, Bentzen SM, Larson G, Tsai H, Sinesi C, Vargas C, Laramore G, Rossi C, Rosen L, Zhu M, Hartsell W. Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09. Clin Transl Radiat Oncol. 2019 Nov; 19:80-86 Epub 2019 Aug 31
    View PubMed
  66. Yu NY, Gamez ME, Hartsell WF, Tsai HK, Laramore GE, Larson GL, Simone CB 2nd, Rossi C, Katz SR, Buras MR, Golafshar MA, Vargas CE, Patel SH. A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors. Adv Radiat Oncol. 2019 Oct-Dec; 4 (4):689-698 Epub 2019 July 16
    View PubMed
  67. DeWees TA, Vargas CE, Golafshar MA, Harmsen WS, Dueck AC. Analytical Methods for Observational Data to Generate Hypotheses and Inform Clinical Decisions. Semin Radiat Oncol. 2019 Oct; 29 (4):311-317
    View PubMed
  68. Mercado CE, Hartsell WF, Simone CB 2nd, Tsai HK, Vargas CE, Zhu HJ, Henderson RH, Zeng J, Larson GL, Hoppe BS. Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries. Acta Oncol. 2019 Jul; 58 (7):1036-1040 Epub 2019 Feb 20
    View PubMed
  69. Badiyan SN, Rutenberg MS, Hoppe BS, Mohindra P, Larson G, Hartsell WF, Tsai H, Zeng J, Rengan R, Glass E, Katz S, Vargas C, Feigenberg SJ, Simone CB 2nd. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies. Pract Radiat Oncol. 2019 Jul - Aug; 9 (4):280-288 Epub 2019 Feb 23
    View PubMed
  70. Vargas CE, Alam NB, Terk M, Niska JR, Cesaretti J, Swartz D, Vashi A, Kasraeian A, West CS, Blasser M, Moore C. Initial results of a randomized phase III trial of high dose image guided radiation with or without androgen deprivation therapy for intermediate-risk prostate cancer. Cancer Treat Res Commun. 2019; 19:100119 Epub 2019 Feb 10
    View PubMed
  71. Niska JR, Thorpe CS, Allen SM, Daniels TB, Rule WG, Schild SE, Vargas CE, Mookadam F. Radiation and the heart: systematic review of dosimetry and cardiac endpoints. Expert Rev Cardiovasc Ther. 2018 Dec; 16 (12):931-950 Epub 2018 Nov 01
    View PubMed
  72. Tseng YD, Hartsell W, Tsai H, Badiyan S, Wang CJ, Rossi C, Kotecha R, Vora S, Vargas C, Larson G, Halasz LM. Proton therapy patterns of care among pediatric and adult patients with CNS tumors. Neuro Oncol. 2018 Oct 9; 20 (11):1556-1557
    View PubMed
  73. Vargas CE, Schmidt MQ, Niska JR, Hartsell WF, Keole SR, Doh L, Chang JH, Sinesi C, Rodriquez R, Pankuch M, Larson GL. Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer. Adv Radiat Oncol. 2018 Jul-Sep; 3 (3):322-330 Epub 2018 Feb 23
    View PubMed
  74. Thorpe CS, Niska JR, Brunnhoelzl DC, McGee LA, Kesslering CM, Hartsell WF, Vargas CE. First report of proton beam therapy for breast angiosarcoma from the prospective PCG registry. Acta Oncol 2018 Jul; 57 (7):992-994 Epub 2018 Jan 05
    View PubMed
  75. Chuong MD, Hartsell W, Larson G, Tsai H, Laramore GE, Rossi CJ, Wilkinson JB, Kaiser A, Vargas C. Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial. Acta Oncol. 2018 Mar; 57 (3):368-374 Epub 2017 Oct 14
    View PubMed
  76. Whitaker TJ, Mayo CS, Ma DJ, Haddock MG, Miller RC, Corbin KS, Neben-Wittich M, Leenstra JL, Laack NN, Fatyga M, Schild SE, Vargas CE, Tzou KS, Hadley AR, Buskirk SJ, Foote RL. Data collection of patient outcomes: one institution's experience. J Radiat Res. 2018 Mar 1; 59 (suppl_1):i19-i24
    View PubMed
  77. Vargas CE, Hartsell WF, Dunn M, Keole SR, Doh L, Eisenbeisz E, Larson GL. Hypofractionated Versus Standard Fractionated Proton-beam Therapy for Low-risk Prostate Cancer: Interim Results of a Randomized Trial PCG GU 002. Am J Clin Oncol. 2018 Feb; 41 (2):115-120
    View PubMed
  78. Vargas CE, Hartsell WF, Dunn M, Keole SR, Doh L, Eisenbeisz E, Larson GL. Hypofractionated versus standard fractionated proton-beam therapy for low-risk prostate cancer interim results of a randomized trial pcg gu 002 American Journal Of Clinical Oncology-cancer Clinical Trials. 2018 Feb; 41 (2):115-20
  79. Vemprala S, Saripalli S, Vargas C, Bues M, Hu Y, Shen J. Real-Time Tumor Tracking for Pencil Beam Scanning Proton Therapy. 2018 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS), Madrid, Spain. 2018; 4434-4440.
  80. Niska JR, Keole SR, Pockaj BA, Halyard MY, Patel SH, Northfelt DW, Gray RJ, Wasif N, Vargas CE, Wong WW. Choosing wisely after publication of level I evidence in breast cancer radiotherapy. Breast Cancer (Dove Med Press). 2018; 10:31-37 Epub 2018 Feb 09
    View PubMed
  81. Gamez ME, Lal D, Halyard MY, Wong WW, Vargas C, Ma D, Ko SJ, Foote RL, Patel SH. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience. Head Neck. 2017 Sep; 39 (9):1819-1824 Epub 2017 May 31
    View PubMed
  82. Howarth AL, Niska JR, Brooks K, Anand A, Bues M, Vargas CE, Mahabir RC. Tissue Expanders and Proton Beam Radiotherapy: What You Need to Know. Plast Reconstr Surg Glob Open. 2017 Jun; 5 (6):e1390 Epub 2017 June 23
    View PubMed
  83. Schild MH, Schild SE, Wong WW, Vora SA, Keole SR, Vargas CE, Daniels TB, Ezzell GA, Nguyen BD, Roarke MC. A Prospective Trial of Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Integrated Boost for Prostate Cancer: Long-term Outcomes Compared With Standard Image Guided IMRT. Int J Radiat Oncol Biol Phys. 2017 Apr 1; 97 (5):1021-1025 Epub 2017 Feb 01
    View PubMed
  84. Goenka A, Newman NB, Fontanilla H, Cahlon O, Chon B, Tsai H, Hug E, Brown C, Vargas C, Parikh RR. Patient-reported Quality of Life After Proton Beam Therapy for Prostate Cancer: The Effect of Prostate Size. Clin Genitourin Cancer. 2017 Mar 18;
    View PubMed
  85. Gamez ME, Halyard MY, Hinni ML, Hayden RE, Nagel TH, Vargas CE, Wong WW, Curtis KK, Zarka MA, Ma D, Patel SH. Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer. Ann Otol Rhinol Laryngol. 2017 Mar; 126 (3):185-191 Epub 2017 Jan 05
    View PubMed
  86. Rana S, Cheng C, Zhao L, Park S, Larson G, Vargas C, Dunn M, Zheng Y. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles. J Med Radiat Sci. 2017 Mar; 64: (1)18-24.
    View PubMed
  87. Chang JM, Kosiorek HE, Dueck AC, Casey WJ, Rebecca AM, Mahabir R, Patel SH, Keole SR, Wong WW, Vargas CE, Halyard MY, Gray RJ, Wasif N, Stucky CH, Pockaj BA. Trends in mastectomy and reconstruction for breast cancer; a twelve year experience from a tertiary care center. Am J Surg. 2016 Dec; 212 (6):1201-1210 Epub 2016 Sept 29
    View PubMed
  88. Hoppe BS, Tsai H, Larson G, Laramore GE, Vargas C, Tseng YD, Dunn M, McGee L, Cahlon O, Hartsell W. Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry. Acta Oncol. 2016 Nov; 55 (11):1378-1380 Epub 2016 Aug 31
    View PubMed
  89. Wilkinson B, Morgan H, Gondi V, Larson GL, Hartsell WF, Laramore GE, Halasz LM, Vargas C, Keole SR, Grosshans DR, Shih HA, Mehta MP. Low Levels of Acute Toxicity Associated With Proton Therapy for Low-Grade Glioma: A Proton Collaborative Group Study. Int J Radiat Oncol Biol Phys. 2016 Oct 1; 96 (2S):E135
    View PubMed
  90. Vargas CE, Hartsell WF, Dunn M, Keole SR, Doh L, Chang J, Larson GL. Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: Analysis of quality of life and toxicity, PCG GU 002. Rep Pract Oncol Radiother. 2016 May-Jun; 21 (3):207-12 Epub 2016 Mar 04
    View PubMed
  91. Liu W, Schild SE, Chang JY, Liao Z, Chang YH, Wen Z, Shen J, Stoker JB, Ding X, Hu Y, Sahoo N, Herman MG, Vargas C, Keole S, Wong W, Bues M. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer. Int J Radiat Oncol Biol Phys. 2016 May 1; 95 (1):523-533 Epub 2015 Nov 10
    View PubMed
  92. Vargas C, Swartz D, Vashi A, Blasser M, Kasraeian A, Cesaretti J, Kiley K, Koziol J, Terk M. Salvage brachytherapy for recurrent prostate cancer. Brachytherapy. 2014 Jan-Feb; 13(1):53-8.
  93. Rana S, Pokharel S, Zheng Y, Zhao L, Risalvato D, Vargas C. Treatment planning study comparing proton therapy, RapidArc and intensity modulated radiation therapy for a synchronous bilateral lung cancer case. Intl J Cancer Therapy Oncol. 2014; 2(2).
  94. Rana S, Cheng C, Zheng Y, Risalvato D, Cersonsky N, Ramirez E, Zhao L, Larson G, Vargas C. Proton therapy vs. VMAT for prostate cancer: a treatment planning study. Intl J Particle Therapy. 2014; 1(1):22-33.
  95. Rana S, Cheng CY, Zheng Y, Hsi W, Zeidan O, Schreuder N, Vargas C. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy. J Applied Clin Med Physics. 2014; 15(3).
  96. Vargas C, Swartz D, Vashi A, Blasser M, Kasareian A, Cesaretti J, Kiley K, Terk M. Long-term outcomes and prognostic factors in patients treated with intraoperatively planned prostate brachytherapy. Brachytherapy. 2013 Mar-Apr; 12(2):120-5.
  97. Ouhib Z, Benda R, Kasper M, Vargas C, Kyriacou A, Lyden M. Accurate verification of balloon rotation correction for the Contura multilumen device for accelerated partial breast irradiation. Brachytherapy. 2011 Jul-Aug; 10(4):325-30.
  98. Martinez AA, Demanes J, Vargas C, Schour L, Ghilezan M, Gustafson GS. High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer. Am J Clin Oncol. 2010 Oct; 33(5):481-8.
  99. Vargas C, Saito AI, Hsi WC, Indelicato D, Falchook A, Zengm Q, Oliver K, Keole S, Dempsey J. Cine-magnetic resonance imaging assessment of intrafraction motion for prostate cancer patients supine or prone with and without a rectal balloon. Am J Clin Oncol. 2010 Feb; 33(1):11-6.
    View PubMed
  100. Chera BS, Vargas C, Morris CG, Louis D, Flampouri S, Yeung D, Duvvuri S, Li Z, Mendenhall NP. Dosimetric study of pelvic proton radiotherapy for high-riskprostate cancer. Int J Radiat Oncol Biol Phys. 2009 Nov 15; 75(4):994-1002.
  101. Hsi WC, Indelicato DJ, Vargas C, Duvvuri S, Li Z, Palta J. In vivo verification of proton beam path by using post-treatment PET/CT imaging. MedPhys. 2009 Sep; 36(9):4136-46.
  102. Saito AI, Lightsey J, Li JG, Copeland EM 3rd, Karasawa K, Vargas CE, Mendenhall NP. Accuracy of breast cancer axillary lymph node treatment plansbased on 2-dimensional imaging: what we should know before interpreting2-dimensional treatment-planning era studies. Am J Clin Oncol Aug. 2009 Aug; 32(4):387-95.
  103. Saito AI, Vargas C, Morris CG, Lightsey J, Mendenhall NP. Differences between current and historical breast cancer axillary lymph node irradiation based on arm position: implications for radiation oncologists. Am J Clin Oncol. 2009 Aug; 32(4):381-6.
    View PubMed
  104. Vargas C, Falchook A, Indelicato D, Yeung A, Henderson R, Olivier K, Keole S, Williams C, Li Z, Palta J. Proton therapy for prostate cancer treatment employing online image guidance and an action level threshold. Am J Clin Oncol. 2009 Apr; 32(2):180-6.
    View PubMed
  105. Yeung AR, Vargas CE, Falchook A, Louis D, Olivier K, Keole S, Yeung D, Mendenhall NP, Li Z. Dose-volume differences for computed tomography and magnetic resonance imaging segmentation and planning for proton prostate cancer therapy. Int J Radiat Oncol Biol Phys. 2008 Dec 1; 72(5):1426-33. Epub 2008 Aug 30.
    View PubMed
  106. Lin L, Vargas C, Hsi W, Indelicato D, Slopsema R, Li Z, Yeung D, Horne D, Palta J. Dosimetric uncertainty in prostate cancer proton radiotherapy. Med Phys. 2008 Nov; 35(11):4800-7.
    View PubMed
  107. Vargas C, Wagner M, Indelicato D, Fryer A, Horne D, Chellini A, McKenzie C, Lawlor P, Mahajan C, Li Z, Lin L, Keole S. Image guidance based on prostate position for prostate cancer proton therapy. Int J Radiat Oncol Biol Phys. 2008 Aug 1; 71(5):1322-8. Epub 2008 May 28.
    View PubMed
  108. Vargas C, Wagner M, Mahajan C, Indelicato D, Fryer A, Falchook A, Horne D, Chellini A, McKenzie C, Lawlor P, Li Z, Lin L, Keole S. Proton therapy coverage for prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2008 Apr 1; 70(5):1492-501.
    View PubMed
  109. Vargas C, Mahajan C, Fryer A, Indelicato D, Horne D, Chellini A, McKenzie C, Lawlor P, Henderson R, Li Z, Lin L, Olivier K, Keole S. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008 Mar; 70(3):744-51. Epub 2007 Sep
  110. Harsolia A, Vargas C, Yan D, Brabbins D, Lockman D, Liang J, Gustafson G, Vicini F, Martinez A, Kestin LL. Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1100-9.
  111. Vargas C, Mahajan C, Fryer A, Indelicato D, Henderson RH, McKenzie C, Horne D, Chellini A, Lawlor P, Li Z, Oliver K, Keole S. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1110-6.
    View PubMed
  112. Sohn M, Yan D, Liang J, Meldolesi E, Vargas C, Alber M. Incidence of laterectal bleeding in high-dose conformal radiotherapy of prostate cancer usingequivalent uniform dose-based and dose-volume-based normal tissue complicationprobability models. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1066-73.
  113. Saito AI, Vargas CE, Benda R, Morris CG, Mendenhall NP. Is the Berg axillary lymph node categorization useful in the 3D environment?. Am J Clinc Oncol. 2007 Feb; 30(1):69-77.
  114. Vargas CE, Demanes J, Boike TP, Barnaba MC, Skoolisariyaporn P, Schour L, Gustafson GS, Gonzalez J, Martinez AA. Matched-pair analysis of prostate cancer patients with a high risk of positive pelvic lymph nodes treated with and without pelvic RT and high-dose radiation using high dose rate brachytherapy. Am J Clin Oncol. 2006 Oct; 29(5):451-7.
  115. Vargas CE, Martinez AA, Boike TP, Spencer W, Goldstein N, Gustafson GS, Krauss DJ, Gonzalez J. High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: results of a phase I to II study. Int J Radiat Oncol BiolPhys. 2006 Oct 1; 66(2):416-23.
  116. Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Gynecol Oncol. 2006 Oct; 103(1):87-93.
  117. Chao KK, Goldstein NS, Yan D, Vargas CE, Ghilezan MI, Korman HJ, Kernen KM, Hollander JB, Gonzalez JA, Martinez AA, Vicini FA, Kestin LL. Clinicopathologic analysis of extracapsular extension in prostate cancer: should the clinical target volume be expanded posterolaterally to account for microscopic extension? Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):999-1007.
  118. Hugo G, Vargas CE, Liang J, Kestin L, Wong JW, Yan D. Changes in the respiratory pattern during radiotherapy for cancer in the lung. Radiother Oncol. 2006 Mar; 73(3):326-31.
  119. Vargas C, Martinez A, Galalae R, Demanes J, Harsolia A, Schour L, Nuernberg N, Gonzalez J. High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features. Prostate Cancer Prostatic Dis. 2006; 9(3):245-53. Epub 2006 Jun 20.
    View PubMed
  120. Vargas CE, Galalae R, Demanes J, Harsolia A, Meldolesi E, Nürnberg N, Schour L, Martinez A. Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation. Int J Radiat Oncol Biol Phys. 2005 Dec 1; 63(5):1474-82.
  121. Vargas CE, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiation Oncol Biology and Physics. 2005 Dec; 73(5):1514-21.
  122. Vargas CE, Go N, Kestin L, Krauss D, Martinez A, Vicini A. Risk factors for isilateral breast tumor recurrence and its impact on cause specific survival in DCIS patients treated with breast conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys. 2005 Dec; 63(5):1514-21. Epub 2005 Jul
  123. Vargas CE, Yan D, Kestin LL, Krauss D, Lockman DM, Brabbins DS, Martinez AA. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: Use of dose-volume constraints to achieve rectal isotoxicity. Int J Radiation Oncol Biology and Physics. 2005 Sep; 63(1):141-9.
  124. Vargas C, Ghilezan M, Hollander M, Gustafson G, Korman H, Gonzalez J, Martinez A. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for either high or low dose rate prostate brachytherapy. J Urol. 2005 Sep; 174(3):882-7.
  125. Vargas CE, Kestin L, Yan D, Grills I, Brabbins DS, Lockman DM, Liang J, Gustafson GS, Chen PY, Vicini FA, Wong JW, Martinez A. Dose-volume analysis of predictors for chronic rectal toxicity following treatment of prostate cancer with high-dose conformal radiotherapy. Int J Radiation Oncol Biology and Physics. 2005 Aug; 62(5):1297-308.
  126. Martinez AA, Demanes DJ, Galalae R, Vargas CE, Bertermann H, Rodriguez R, Gustafson G, Altieri G, Gonzalez J. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofracionated regime . Int J Radiation Oncol Biology Physics. 2005 Aug; 62(5):1322-31.
  127. Letourneau D, Martinez A, Lockman D, Yand D, Vargas CE, Invaldi G, Wong J. Assessment of residual error for online cone beam CT guided treatment of prostate patients. Int J Radiation Oncol Biology and Physics. 2005 Jul; 62(4):1239-46.
  128. Jolly S, Vargas CE, Kumar T, Weiner S, Brabbins D, Chen P, Floyd W, Martinez AA. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. Gynecol Oncol. 2005 Jun; 97(3):887-92.
  129. Vicini FA, Vargas CE, Abner A, Kestin LL, Horwitz E, Martinez A. Limitations in the use of serum prostate specific angigen levels to monitor patients after treatement for prostate cancer. J Urol. 2005 may; 173(5):1456-62.
  130. Krauss DJ, Kestin LL, Raff G, Yan D, Wong J, Gentry R, Letts N, Vargas CE, Martinez AA, Vicini FA. MRI-based volumetric assessment of cardiac anatomy and dose reduction via active breathing control during irradiation for left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2005 Mar 15; 61(4):1243-50.
  131. Vargas CE, Kestin LL, Week D, Krauss D, Vicini FA, Martinez A. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Int J Radiation Oncol Biology and Physics. 2005 Mar; 61(3):714-72.
  132. Vicini FA, Vargas CE, Gustafson G, Edmundson G, Martinez A. High dose rate brachytherapy in the treatment of prostate cancer. World Journal of Urology. 2003 Sep; 21(4):220-8.
  133. Vicini FA, Vargas CE, Edmundson G, Kestin L, Martinez A. The role of high-dose rate brachytherapy in locally advanced prostate cancer. Semin Rad Oncol. 2003 Apr; 13(2):98-108.